BioCentury | Jun 11, 2020
Finance

Checkmate raises $85M series C to support new indications for TLR9 agonist

...Checkmate raised $85 million in a series C round to advance lead program CMP-001 across a...
...as well as existing investors Sofinnova Investments, venBio Partners, F-Prime Capital Partners, and Decheng Capital. CMP-001...
...Kumar joined the board. Targets TLR9 - Toll-like receptor 9 Danielle Kopke, Staff Writer CMP-001, cyt003, cyt003-qbg10, QbG10 Keytruda...
BioCentury | Dec 14, 2018
Financial News

Checkmate raises $22M as Krieg hands off CEO role

...and CEO of innate immune activation company Biothera Pharmaceuticals Inc. (Eagan, Minn.). Checkmate's lead compound, CMP-001...
...treatment. At April's American Association for Cancer Research meeting in Chicago, Checkmate reported that intratumoral CMP-001...
...Checkmate has raised $74 million to date. Checkmate Pharmaceuticals Inc., Cambridge, Mass. Allison Johnson CMP-001, cyt003, cyt003-qbg10, QbG10 Checkmate...
BioCentury | Dec 13, 2018
Financial News

Checkmate raises $22M as Krieg hands off CEO role

...and CEO of innate immune activation company Biothera Pharmaceuticals Inc. (Eagan, Minn.). Checkmate's lead compound, CMP-001...
...treatment. At April's American Association for Cancer Research meeting in Chicago, Checkmate reported that intratumoral CMP-001...
...provide runway into late 2019. Checkmate has raised $74 million to date. Allison Johnson CMP-001, cyt003, cyt003-qbg10, QbG10 Checkmate...
BioCentury | Jun 14, 2018
Tools & Techniques

Imaging immunotherapy

...our trials,” he said. Checkmate recently reported positive Phase I data from its TLR9 agonist CMP-001...
BioCentury | Apr 20, 2018
Product Development

Lessons from the ECHO chamber

...patients so that those who didn’t respond before will.” Checkmate’s toll-like receptor 9 (TLR9) agonist CMP-001...
...single-arm studies if you have the right patients.” Michael Gladstone, Atlas Venture Checkmate’s lead candidate CMP-001...
...that among 69 evaluable patients with advanced metastatic melanoma that is resistant to PD-1/PD-L1 inhibitors, CMP-001...
BioCentury | Apr 20, 2018
Clinical News

Checkmate's CMP-001 among TLR9 agonist combo data highlighted at AACR

...Mass.) reported data from the CMP-001 plus Keytruda arm of the open-label, U.S. Phase Ib CMP-001-001...
...registration pathway for CMP-001 with FDA, which could include seeking accelerated approval of the candidate. CMP-001...
...and progression-free survival (PFS) (Phase II) Status: Phase Ib/II data Milestone: NA Chris Lieu CMP-001, cyt003, cyt003-qbg10, QbG10 SD-101...
BioCentury | Apr 17, 2018
Clinical News

Checkmate's CMP-001 among TLR9 agonist combo data highlighted at AACR

...Inc. (Cambridge, Mass.) reported data from the CMP-001 plus Keytruda arm of the Phase Ib CMP-001-001...
...registration pathway for CMP-001 with FDA, which could include seeking accelerated approval of the candidate. CMP-001...
...responses, in the seven patients. Dynavax added $1.25 to $20.10 on Tuesday. Chris Lieu CMP-001, cyt003, cyt003-qbg10, QbG10 IMO-2125 SD-101...
BioCentury | Jun 15, 2017
Financial News

Checkmate raises $27M, names COO

...operations at Forum Pharmaceuticals Inc. (Waltham, Mass.). An ongoing Phase Ib trial is evaluating Checkmate's CMP-001...
...refractory melanoma patients who have progressed on or failed to respond to anti- PD-1 therapy. CMP-001...
...undisclosed new tumor indication by 1Q18. Checkmate also intends to seek breakthrough therapy designation for CMP-001...
BioCentury | Dec 16, 2016
Company News

Genocea, Checkmate deal

...Checkmate’s Phase Ib trial of CMP-001 plus Keytruda pembrolizumab. Checkmate has exclusive, worldwide rights to CMP-001...
...with Cytos Biotechnology AG in December 2015 to form Kuros Biosciences Ltd. (SIX:KURN; Schlieren, Switzerland). CMP-001...
...Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Checkmate Pharmaceuticals Inc. , Cambridge, Mass. Business: Cancer Jaime De Leon CMP-001 Checkmate...
BioCentury | Jul 28, 2016
Targets & Mechanisms

Making sense of sensors

...patient and then the anti-PD-1 can work," Krieg said. Checkmate has the CpG DNA oligo CMP-001...
Items per page:
1 - 10 of 85